Neurological pupil index

New Multicenter Study Reveals Neurological Pupil index™ (NPi) as Predictor of Outcome and Mortality in Brain Injury Patients

Retrieved on: 
Thursday, September 7, 2023

The primary aim of the study was to investigate the association between NPi and 6-month neurological outcomes and mortality.

Key Points: 
  • The primary aim of the study was to investigate the association between NPi and 6-month neurological outcomes and mortality.
  • Patients' NPi scores were measured using NeurOptics' NPi Pupillometer every four hours during the initial seven days of admission.
  • "Tracking a patient's NPi score dynamically predicts their neurological outcome and mortality over a 6-month period.
  • The study, titled "The Neurological Pupil Index for Outcome Prognostication in People with Acute Brain Injury (ORANGE): A Prospective, Observational, Multicenter Cohort Study," is accessible here .

New Clinical Study Shows NeurOptics’ Neurological Pupil Index™, an Important Value for Assessing Brain Injury, is Unaffected by Clinical Intoxication

Retrieved on: 
Tuesday, January 10, 2023

A newly published clinical study shows that NeurOptics’ Automated Pupillometry and the Neurological Pupil index™ (NPi®) remain unaffected by clinical intoxication, and therefore can be used for rapidly screening emergency room patients for brain injury or neurological injuries regardless of intoxicated state.

Key Points: 
  • A newly published clinical study shows that NeurOptics’ Automated Pupillometry and the Neurological Pupil index™ (NPi®) remain unaffected by clinical intoxication, and therefore can be used for rapidly screening emergency room patients for brain injury or neurological injuries regardless of intoxicated state.
  • View the full release here: https://www.businesswire.com/news/home/20230110005401/en/
    NeurOptics’ automated pupillometer has emerged as an important technology that provides a reliable measurement of pupil size and reactivity, expressed as the Neurological Pupil index (NPi).
  • The results showed that although clinical intoxication did affect pupil size and other individual metrics of the pupillary light reflex, no statistical differences in the NPi were noted between those with intoxication versus control patients.
  • NPi remained unaffected by clinical intoxication and therefore can potentially be used for ED patient evaluation without risk of confounding by key intoxicants of abuse.

NeurOptics’ Neurological Pupil index™ and Automated Pupillometry Included in Latest European Guidelines for Post-Resuscitation Care

Retrieved on: 
Tuesday, December 13, 2022

NeurOptics Neurological Pupil index (NPi) and automated pupillometry are now included in the updated 2021 European Resuscitation Council (ERC) and European Society of Intensive Care Medicine (ESICM) Guidelines for post-resuscitation care as an objective measurement supporting neurological prognosis in patients following cardiac arrest.

Key Points: 
  • NeurOptics Neurological Pupil index (NPi) and automated pupillometry are now included in the updated 2021 European Resuscitation Council (ERC) and European Society of Intensive Care Medicine (ESICM) Guidelines for post-resuscitation care as an objective measurement supporting neurological prognosis in patients following cardiac arrest.
  • The guidelines were last updated in 2015 and reflect alignment with the International Liaison Committee on Resuscitation (ILCOR) and associated member councils.
  • NeurOptics NPi Pupillometry has emerged as an important technology that provides a quantitative measurement of pupil size and reactivity, expressed as the Neurological Pupil index (NPi).
  • : Adult advanced life support: 2020 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations.

New Peer-Reviewed Study Leverages NeurOptics’ Automated Pupillometry to Measure Pupil Reactivity Differences, an Earlier Indicator of Neurological Injury

Retrieved on: 
Wednesday, September 14, 2022

A new peer-reviewed study shows that even one occurrence of an abnormal Neurological Pupil index (NPi) differential, measured by NeurOptics NPi Pupillometer, can be an early indicator of neurological injury.

Key Points: 
  • A new peer-reviewed study shows that even one occurrence of an abnormal Neurological Pupil index (NPi) differential, measured by NeurOptics NPi Pupillometer, can be an early indicator of neurological injury.
  • Automated pupillometry has emerged as an important technology that provides a quantitative measurement of pupil size and reactivity, expressed as the Neurological Pupil index (NPi).
  • Patients were assessed using NeurOptics automated pupillometer to objectively measure pupil size and reactivity, NPi, in each eye and calculate the NPi differential.
  • NeurOptics quantitative automated pupillometer provides a reliable measurement of pupil size and reactivity and tracks changes over time, allowing for earlier intervention for patients with brain injury and those at risk of secondary neurological injury.

NeurOptics Expands Globally, Launching NPi®-300 Automated Pupillometer in 15 International Countries

Retrieved on: 
Tuesday, May 3, 2022

The NPi-300 Pupillometer is an automated pupillometer that enhances pupillary assessment to assist in detecting cerebral insult, guiding treatment and informing prognosis for clinicians and their patients.

Key Points: 
  • The NPi-300 Pupillometer is an automated pupillometer that enhances pupillary assessment to assist in detecting cerebral insult, guiding treatment and informing prognosis for clinicians and their patients.
  • View the full release here: https://www.businesswire.com/news/home/20220503005628/en/
    NeurOptics' NPi-300, a next-generation automated pupillometer that enhances pupillary assessment to assist in detecting cerebral insult, is now available in 15 countries internationally.
  • The new NPi-300 provides a number of enhanced features to improve functionality, including:
    Our NPi-300 Pupillometer is the gold standard in pupillometry, and we are thrilled to deliver this advanced, next-generation pupillometer to our international customers, said William Worthen, President and CEO, NeurOptics.
  • The NPi-300 Pupillometer, along with the Neurological Pupil index (NPi) scale, provide clinicians with the information needed to make more informed treatment decisions.

 Inova Health System Expands Adoption of NeurOptics’ Pupillometers in ICUs, Stroke Units and Emergency Departments

Retrieved on: 
Tuesday, July 20, 2021

Inova has implemented 135 devices in five hospitals across 20 critical care units and five emergency departments.

Key Points: 
  • Inova has implemented 135 devices in five hospitals across 20 critical care units and five emergency departments.
  • Automated infrared pupillometry using NeurOptics NPi Pupillometer provides nurses and clinicians with an objective assessment of the pupillary light reflex.
  • The NPi Pupillometer measures pupil size and reactivity, which is expressed numerically on the Neurological Pupil index (NPi).
  • Our mission is to provide world-class healthcare every time, every touch to each person in every community we have the privilege to serve.

NeurOptics Launches New NPi®-300 Automated Pupillometer

Retrieved on: 
Thursday, July 8, 2021

The new NPi-300 Pupillometer includes several enhanced features to improve functionality, including:

Key Points: 
  • The new NPi-300 Pupillometer includes several enhanced features to improve functionality, including:
    We are excited to launch this advanced, next-generation pupillometer, said William Worthen, President and CEO, NeurOptics.
  • The NPi-300 Pupillometer, along with the Neurological Pupil index (NPi) scale, provides clinicians with the information needed to make better treatment decisions.
  • Automated pupillometry has emerged as an important technology that provides a quantitative measurement of pupil size and reactivity, expressed as the Neurological Pupil index (NPi).
  • The NeurOptics NPi Pupillometer has been included in more than 70 clinical studies, adopted in over 490 hospitals in the United States, and is represented in more than 27 countries worldwide.

Case Study Series Published in Journal of Neuroscience Nursing Demonstrates NeurOptics’ Pupillometry is Key Tool for Neurological Assessment

Retrieved on: 
Tuesday, May 11, 2021

b'A new case study series published in the Journal of Neuroscience Nursing demonstrated that automated infrared pupillometry is an accurate tool that provides reliable data in patients with a poor baseline neurological examination after stroke.

Key Points: 
  • b'A new case study series published in the Journal of Neuroscience Nursing demonstrated that automated infrared pupillometry is an accurate tool that provides reliable data in patients with a poor baseline neurological examination after stroke.
  • The study examined the reliability and accuracy of automated pupillometry for neurological assessments.
  • Patients were monitored hourly using NeurOptics\xe2\x80\x99 infrared automated pupillometer, which calculates a Neurological Pupil index (NPi).
  • In each case, abnormal NPi values prompted emergent imaging that confirmed acute cerebral edema, resulting in a change in management and treatment plan.

NeurOptics Launches Pupillometry Program at Vanderbilt University Medical Center

Retrieved on: 
Thursday, March 25, 2021

As a comprehensive stroke center, Vanderbilt has one of the largest Neuro ICUs in the country, treating patients from all over the southeastern region of the United States.

Key Points: 
  • As a comprehensive stroke center, Vanderbilt has one of the largest Neuro ICUs in the country, treating patients from all over the southeastern region of the United States.
  • We are proud to support Vanderbilt University Medical Center as it implements pupillometry in its award-winning Neuro ICU, said Kathleen Pierson, Vice President, Global Sales and Marketing.
  • Automated infrared pupillometry is an objective assessment of the pupillary light reflex that is measured using NeurOptics NPi-200 Pupillometer.
  • Headquartered in Irvine, Calif., NeurOptics is the leader in the science of pupillometry.

NeurOptics Launches Virtual Pupillometry Education Platform

Retrieved on: 
Tuesday, February 23, 2021

NeurOptics , the leader in the science of pupillometry, has launched its Pupillometry Education Symposiums platform, which includes a series of both product and clinical-focused presentations that demonstrate the essential role pupillometry and the Neurological Pupil index (NPi) play in the assessment and screening of patients at risk of neurological injury.

Key Points: 
  • NeurOptics , the leader in the science of pupillometry, has launched its Pupillometry Education Symposiums platform, which includes a series of both product and clinical-focused presentations that demonstrate the essential role pupillometry and the Neurological Pupil index (NPi) play in the assessment and screening of patients at risk of neurological injury.
  • Clinical-focused programs have been approved by the American Association of Critical-Care Nurses (AACN) for Continuing Education Recognition Points (CERPs).
  • As COVID-19 continues to impact clinicians ability to attend in-person programs, we are pleased to offer our Pupillometry Education Symposium platform to provide additional options for training and education that demonstrates the clinical utility of the pupillometer and the NPi scale for monitoring patients with brain injury, said William Worthen, President and CEO at NeurOptics.
  • Automated infrared pupillometry is an objective assessment of the pupillary light reflex that is measured using NeurOptics NPi-200 Pupillometer.